PURPOSE: We employed user-centered design to refine a prototype of the eyeGuide, a novel, tailored behavior change program intended to improve medication adherence among glaucoma patients. PATIENTS: Glaucoma patients age 40 years and above prescribed ≥1 glaucoma medication were included. METHODS: The eyeGuide consists of tailored educational content and tailored testimonials in which patients share how they were able to overcome barriers to improve their medication adherence. A hybrid of semistructured diagnostic and pretesting interviews were used to refine the content of the eyeGuide. Purposeful sampling was used to recruit a study population representative of the glaucoma patient population. Interviews were conducted until thematic saturation was reached. Interviews were audiorecorded and transcribed verbatim. Three researchers analyzed the transcripts, generated a codebook, and identified key themes using NVivo 10.0 to further refine the eyeGuide. RESULTS: Twenty-one glaucoma patients were interviewed; mean age 72±12.4 years, 5 (24%) African Americans, 9 (43%) with poor self-reported adherence, 10 (47.6%) age 75 years and above, 10 (47.6%) with poor vision, and 9 (42.9%) women. Qualitative analysis identified 5 important themes for improving glaucoma self-management: social support, patient-provider relationship, medication routine, patients' beliefs about disease and treatment, and eye drop instillation. All participants expressed satisfaction with in-person delivery of the eyeGuide and preferred this to a Web-based module. Participant feedback resulted in revised content. CONCLUSIONS: User-centered design generated improvements in the eyeGuide that would not have been possible without patient input. Participants expressed satisfaction with the tailored content.
PURPOSE: We employed user-centered design to refine a prototype of the eyeGuide, a novel, tailored behavior change program intended to improve medication adherence among glaucomapatients. PATIENTS: Glaucomapatients age 40 years and above prescribed ≥1 glaucoma medication were included. METHODS: The eyeGuide consists of tailored educational content and tailored testimonials in which patients share how they were able to overcome barriers to improve their medication adherence. A hybrid of semistructured diagnostic and pretesting interviews were used to refine the content of the eyeGuide. Purposeful sampling was used to recruit a study population representative of the glaucomapatient population. Interviews were conducted until thematic saturation was reached. Interviews were audiorecorded and transcribed verbatim. Three researchers analyzed the transcripts, generated a codebook, and identified key themes using NVivo 10.0 to further refine the eyeGuide. RESULTS: Twenty-one glaucomapatients were interviewed; mean age 72±12.4 years, 5 (24%) African Americans, 9 (43%) with poor self-reported adherence, 10 (47.6%) age 75 years and above, 10 (47.6%) with poor vision, and 9 (42.9%) women. Qualitative analysis identified 5 important themes for improving glaucoma self-management: social support, patient-provider relationship, medication routine, patients' beliefs about disease and treatment, and eye drop instillation. All participants expressed satisfaction with in-person delivery of the eyeGuide and preferred this to a Web-based module. Participant feedback resulted in revised content. CONCLUSIONS: User-centered design generated improvements in the eyeGuide that would not have been possible without patient input. Participants expressed satisfaction with the tailored content.
Authors: Michael S Spencer; Ann-Marie Rosland; Edith C Kieffer; Brandy R Sinco; Melissa Valerio; Gloria Palmisano; Michael Anderson; J Ricardo Guzman; Michele Heisler Journal: Am J Public Health Date: 2011-06-16 Impact factor: 9.308
Authors: Gemma C M Rossi; Gian Maria Pasinetti; Luigia Scudeller; Rosella Radaelli; Paolo Emilio Bianchi Journal: Eur J Ophthalmol Date: 2011 Jul-Aug Impact factor: 2.597
Authors: Paula Anne Newman-Casey; Alan L Robin; Taylor Blachley; Karen Farris; Michele Heisler; Ken Resnicow; Paul P Lee Journal: Ophthalmology Date: 2015-04-24 Impact factor: 12.079
Authors: Paula Anne Newman-Casey; Olivia Killeen; Sarah Miller; Chamisa MacKenzie; Leslie M Niziol; Ken Resnicow; John W Creswell; Paul Cook; Michele Heisler Journal: Health Commun Date: 2018-12-20
Authors: Paula Anne Newman-Casey; Olivia J Killeen; Morgan Renner; Alan L Robin; Paul Lee; Michele Heisler Journal: Telemed J E Health Date: 2018-04-23 Impact factor: 3.536
Authors: Paula A Newman-Casey; John A Musser; Leslie M Niziol; Michele M Heisler; Shivani S Kamat; Manjool M Shah; Nish Patel; Amy M Cohn Journal: J Glaucoma Date: 2019-05 Impact factor: 2.503
Authors: Dena Ballouz; Juno Cho; Maria A Woodward; Angela R Elam; David C Musch; Jason Zhang; Sayoko E Moroi; Leroy Johnson; Jean Cederna; Paula A Newman-Casey Journal: J Glaucoma Date: 2021-05-01 Impact factor: 2.290
Authors: Kristen M Peterson; Carrie E Huisingh; Christopher Girkin; Cynthia Owsley; Lindsay A Rhodes Journal: Patient Prefer Adherence Date: 2018-05-09 Impact factor: 2.711
Authors: Paula Anne Newman-Casey; Leslie M Niziol; Chamisa K Mackenzie; Kenneth Resnicow; Paul P Lee; David C Musch; Michele Heisler Journal: Pilot Feasibility Stud Date: 2018-07-23